Blood autoantibody and cytokine profiles predict response to anti-tumor necrosis factor therapy in rheumatoid arthritis

Wolfgang Hueber, Beren H. Tomooka, Franak Batliwalla, Wentian Li, Paul A. Monach, Robert J. Tibshirani, Ronald F. van Vollenhoven, Jon Lampa, Kazuyoshi Saito, Yoshiya Tanaka, Mark C. Genovese, Lars Klareskog, Peter K. Gregersen, William H. Robinson

Research output: Contribution to journalArticleAcademicpeer-review

99 Citations (Scopus)

Abstract

Introduction Anti-TNF therapies have revolutionized the treatment of rheumatoid arthritis ( RA), a common systemic autoimmune disease involving destruction of the synovial joints. However, in the practice of rheumatology approximately one-third of patients demonstrate no clinical improvement in response to treatment with anti-TNF therapies, while another third demonstrate a partial response, and one-third an excellent and sustained response. Since no clinical or laboratory tests are available to predict response to anti-TNF therapies, great need exists for predictive biomarkers. Methods Here we present a multi-step proteomics approach using arthritis antigen arrays, a multiplex cytokine assay, and conventional ELISA, with the objective to identify a biomarker signature in three ethnically diverse cohorts of RA patients treated with the anti-TNF therapy etanercept. Results We identified a 24-biomarker signature that enabled prediction of a positive clinical response to etanercept in all three cohorts ( positive predictive values 58 to 72%; negative predictive values 63 to 78%). Conclusions We identified a multi-parameter protein biomarker that enables pretreatment classification and prediction of etanercept responders, and tested this biomarker using three independent cohorts of RA patients. Although further validation in prospective and larger cohorts is needed, our observations demonstrate that multiplex characterization of autoantibodies and cytokines provides clinical utility for predicting response to the anti-TNF therapy etanercept in RA patients
Original languageEnglish
Pages (from-to)R76
JournalArthritis research & therapy
Volume11
Issue number3
DOIs
Publication statusPublished - 2009
Externally publishedYes

Cite this